LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-05-20 and is reviewed periodically as new material appears.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Fripp was dissatisfied with the quality of the new music being developed by the band, and longstanding friction between himself and Bruford resurfaced. The resulting atmosphere and the lack of workable material almost broke the band up altogether. Instead, the six members opted to work in four smaller groups (or "fraKctalisations", as Fripp called them) known as ProjeKcts. This enabled the group to continue developing ideas and searching for a new direction without the practical difficulty and expense of convening all six musicians at once. From late 1997 to early 1999, ProjeKct One (Fripp, Bruford, Levin, Gunn), ProjeKct Two (Fripp, Belew, Gunn), ProjeKct Three (Fripp, Gunn, Mastelotto), and ProjeKct Four (Fripp, Levin, Gunn, Mastelotto) played live in the United States and the United Kingdom, with recordings from these performances released on The ProjeKcts box set in 1999. These largely-improvised recordings, along with ProjeKct Two's 1998 studio album Space Groove, showed influences including jazz, industrial, techno and drum and bass. Music critic J. D. Considine considered the ProjeKcts' work "frequently astonishing" but lacking in melody. The four live performances of ProjeKct One in December 1997 would be Bruford's last involvement with King Crimson.
Under the third type of abuse, (c) unlawful discrimination, in British Airways plc v Commission it was held that British Airways abused its dominant position by giving some travel agents extra payment to promote its tickets over others. This made "market entry very difficult" and frustrated the ability of "co-contractors to choose between various sources of supply or commercial partners". Under (d) examples of the abuse of imposing supplementary obligations include the Microsoft Corp v Commission case, where Microsoft bundled a pre-installed media player into Windows OS sales, which had the effect of damaging competitor businesses such as RealPlayer. By contrast, in Intel Corp v Commission, Intel was fined €1.06 billion by the commission for giving rebates on x86 computer processors if manufacturers bought over 80% of their chips only from Intel. This had the effect of "tying customers to the undertaking in a dominant position". However the fine was annulled on the ground that the commission had not adequately proven an anti-competitive effect, so in 2023 the Commission imposed a smaller €376 million fine. Second, the Merger Regulation 2004 applies to "concentrations" (any merger or acquisition), that generally have a value of at least €100 million turnover in the EU if it "would significantly impede effective competition" by creating or strengthening a dominant position.
The ultrasound examination allows morphological changes in the kidneys in more detail. In addition to changes in size and shape, renal cysts, localized (focal) organ damage, water sac kidneys and urinary retention as well as tumors can also be visualized. Hardly defined (diffuse) organ changes are accompanied by changes in echogenicity, but can only rarely be assigned to defined diseases. Pulsed Wave Doppler" can also be used to detect circulatory disorders. Calcification (nephrocalcinosis) is also common in chronic kidney disease and can also be detected sonographically. Renal biopsy is not routinely used, but may be indicated in certain preliminary reports—for example, young Abyssinian cats with symptoms of kidney disease for the detection of amyloidosis. Although computed tomography and magnetic resonance imaging have very good detail recognition, they only play a subordinate role in veterinary medicine due to their high costs and limited availability.
Sources: en.wikipedia.org
The complex anion [Lr(C5H4SiMe3)3]− is expected to be stable with a configuration of 6d1 for lawrencium; this 6d orbital would be its highest occupied molecular orbital. This is analogous to the electronic structure of the analogous lutetium compound.
== Function == NPR1 is a membrane-bound guanylate cyclase that serves as the receptor for both atrial and brain natriuretic peptides (ANP and BNP, respectively). It is localized in the kidney where it results in natriuresis upon binding to natriuretic peptides. However, it is found in even greater quantity in the lungs and adipocytes.
Bully: Kevin Garcia Height: 5'11 Weight: 175 lbs. Victim(s): Anthony (co-worker) and Sam Fighter: Tyron Woodley Height: 5'9 Weight: 182 lbs. Money earned by Bully: $1,000 Money earned by victim(s): $9,000 Original airing:
Sources: en.wikipedia.org
Potter (1842), officer during the American Civil War Augustus van Horne Ellis* (1844), Civil War general William Cutting* (1851), lawyer and soldier Henry Eugene Davies (1857), Civil War general William McNeill Whistler* (1857), Confederate soldier and surgeon, brother of James Abbott McNeill Whistler Alfred Thayer Mahan* (1858), president, U.S. Naval War College and author of The Influence of Sea Power Upon History William Jay (1859), soldier and lawyer, 40th president of the Saint Nicholas Society of the City of New York and great-grandson of first U.S. chief justice John Jay Alister Greene (1875), soldier and leader during the Gilded Age Duncan Elliot (1884), soldier and banker Hamilton Fish II (1895), first American killed in the Spanish–American War Ulysses S. Grant III* (1902), grandson of Ulysses S. Grant, entered with the class of 1902 but transferred to United States Military Academy Donald Armstrong (1909), brigadier general and commandant of the Army Industrial College John H. Hilldring* (1916), U.S. major general and former assistant secretary of state for occupied areas Melvin Krulewitch (1916), U.S. major general and president of the New York State Athletic Commission John F. "Jack" Hasey* (1940), American captain in the French Foreign Legion; recipient of the Order of Liberation
=== Back to Trials === In February 2019, SHIELD Illinois partnered with the United States District Court for the Northern District of Illinois to provide SARS-CoV-2 screening to jurors, attorneys, employees, and other courthouse visitors. The program required all jurors to test with SHIELD Illinois before reporting for voir dire while employees were tested weekly. This partnership allowed jury trials to resume in the Northern District while maintaining a safe and healthy working environment for everyone involved.
Using molecular oxygen alkanes can be oxidized to form alcohols, secondary alcohols to ketones, acetals to esters and alkenes to epoxides. Amides can be converted into carbonyl compounds with N-hydroxyphthalimide and cobalt(II)salts under mild conditions.
=== Prescription trends === Between 1998 and 2017, along with imipramine, amitriptyline was the most commonly prescribed first antidepressant for children aged 5–11 years in England. It was also the most prescribed antidepressant (along with fluoxetine) for 12- to 17-year-olds.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.